Aristolochia Bracteolata

Aristolochia bracteolata  Lam.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym A. bracteata Retz.
Family Aristolochiaceae.
Habitat Uttar Pradesh, Bengal, Madhya Pradesh and western peninsular India.
English Bracteated Birthwort.
Ayurvedic Kitamaari, Dhumrapatraa, Naakuli.
Unani Kiraamaar.
Siddha / Tamil Aadutheendaappaalai, Kattusuragam.
Action Oxytocic, abortifacient, emmenagogue.
Taxonomic Cohort Genus Aristolochia (3 documented species); Family Aristolochiaceae (4 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Aristolochia bracteolata (taxonomically cited with authority Lam.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Aristolochiaceae (primary family classification: Aristolochiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy A. bracteata Retz, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Uttar Pradesh, Bengal, Madhya Pradesh and western peninsular India.

Across classical and vernacular Indian systems of medicine, Aristolochia bracteolata is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Bracteated Birthwort; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Kitamaari, Dhumrapatraa, Naakuli; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Kiraamaar; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Aadutheendaappaalai, Kattusuragam. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Aristolochia bracteolata are: Oxytocic, abortifacient, emmenagogue. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Aristolochia bracteolata establish the following evidence base: Leaves and fruit contain ceryl alcohol, aristolochic acid and beta-sitosterol. Aristolochic acid is insecticidal, poisonous, nephrotoxic. Leaf juice— vermifuge. Seeds—strong purgative. Products containing aristolochic acid are banned in the U.S., Canada, Great Britain, European countries and Japan. The seed compounds, aristolochic acid and magnoflorine, induce contractions in the isolated uterus of pregnant rat and stimulate the isolated ileum of guinea pig. They also activate the muscarinic and serotonergic receptors in a variety of organs. Magnoflorine decreases arterial blood pressure in rabbits, and induces hypothermia in mice. See also A. longa.

image2

Botanical Reference 1: Aristolochia bracteolata — Botanical specimen

image3

Botanical Reference 2: Aristolochia bracteolata — Botanical specimen

image3

Botanical Reference 3: Aristolochia bracteolata — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Aristolochia comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Aristolochia indica (Action: Oxytocic, abortifacient, emmenagogue); Aristolochia longa (Action: Oxytocic, abortifacient, emmenagogue). Comparing Aristolochia bracteolata alongside its congeners in genus Aristolochia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Aristolochiaceae encompasses 4 documented medicinal species (0.22% of the 1,814-species flora). Other representative medicinal members of Aristolochiaceae include: Aristolochia indica (Ishvari), Aristolochia longa (European Birthwort), Asarum europaeum (Asarbacca). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 4 medicinal species of family Aristolochiaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Aristolochia bracteolata follow the plant-part modalities specified under its therapeutic action (Oxytocic, abortifacient, emmenagogue), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Aristolochia bracteolata integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top